Diagnosis and management of polycystic ovary syndrome: A practical guide

Drugs

Volumn 66, Issue 7, 2006, Pages 903-912

  Stankiewicz, Marcin ^a,c   Norman, Robert ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Repromed   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANDROGEN RECEPTOR; ANTIANDROGEN; ANTIESTROGEN; CLOMIFENE CITRATE; CYPROTERONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTRADIOL VALERATE; ESTROGEN; ETHINYLESTRADIOL; FLUTAMIDE; FOLLITROPIN; GLITAZONE DERIVATIVE; GONADOTROPIN DERIVATIVE; INSULIN SENSITIZING AGENT; KETOCONAZOLE; MEDROXYPROGESTERONE; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE ACETATE; OPIATE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PIOGLITAZONE; PROGESTERONE DERIVATIVE; ROSIGLITAZONE; SPIRONOLACTONE; TROGLITAZONE; UNINDEXED DRUG; WARFARIN;

AGRANULOCYTOSIS; ANOVULATION; ATAXIA; BREAST DISEASE; BREAST TUMOR; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONFUSION; DEPRESSION; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DROWSINESS; DRUG ACTIVITY; DRUG INHIBITION; DYSLIPIDEMIA; ENDOCRINE DISEASE; ENDOMETRIUM HYPERPLASIA; FATIGUE; FEMALE INFERTILITY; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HIRSUTISM; HUMAN; HYPERANDROGENISM; HYPERTRICHOSIS; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LETHARGY; LEUKOPENIA; LIVER DISEASE; MASTALGIA; MENSTRUATION DISORDER; METABOLIC SYNDROME X; METRORRHAGIA; MULTIPLE PREGNANCY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OLIGOMENORRHEA; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PREGNANCY DIABETES MELLITUS; PRURITUS; RASH; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP APNEA SYNDROME; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; UTERUS BLEEDING; VOMITING; WEIGHT GAIN;

FEMALE; HIRSUTISM; HUMANS; INFERTILITY; MENSTRUATION DISTURBANCES; POLYCYSTIC OVARY SYNDROME; PRACTICE GUIDELINES;

EID: 33744922118     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200666070-00002     Document Type: Review

References (18)

1. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181-91
2. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19 (1): 41-7
3. Norman RJ, Wu R, Stankiewicz MT. Polycystic ovary syndrome. Med J Aust 2004 Feb 2; 180 (3): 132-7
4. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. 7th ed. Philadelphia (PA): Lippincott Williams and Wilkins, 2005
5. Yildirim B, Kaleli B. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril 2003; 79: 1358-64
6. Pasquali R, Casimirri F, Venturoli S, et al. Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome. Metab Clin Exp 1994; 43 (6): 706-13
7. Pierpoint T, McKeigue PM, Isaacs AJ, et al. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 1998; 51: 581-6
8. Wild R, Painter P, Coulson P, et al. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metabl 1985; 61: 946-51
9. Pierpoint T, McKeigue PM, Isaacs AJ, et al. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 1998; 51: 581-6
10. Vgontzas AN, Legro RS, Bixler EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 2001; 86: 517-20
11. Fogel RB, Malhotra A, Pillar G, et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2001; 86: 1175-80
12. Trent M, Austin SB, Rich M, Gordon CM. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr 2005 Mar-Apr; 5 (2): 107-11
13. Lord JM, Flight IHK, Norman RJ. Insulin-sensitizing drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiroinositol) for polycystic ovary syndrome. The Cochrane Database of Systematic Reviews 2003, (2) CD003053
14. Palomba S, Orio F, Falbo A, et al. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005 Jul; 90 (7): 4068-74
15. Farquhar C, Vandekerckhove P, Lilford R. Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2003
16. Van der Spuy ZM, le Roux PA. Cyproterone acetate for hirsutism. The Cochrane Database of Systematic Reviews 2003, (4) CD001125
17. Grigoriou O, Papadias C, Konidaris S, et al. Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomized controlled trial. Gynecol Endocrinol 1996 Apr; 10 (2): 119-23
18. Balfour JA, McClellan K. Topical eflornithine. Am J Clin Dermatol 2001; 2 (3): 197-201